CDKN2A and neoplasm: As an inhibitor of the Cyclin-Dependent Kinase 4/6 (CDK4/6), the Cyclin-Dependent Kinase Inhibitor p16 (p16) has regulatory roles of CDK4/6 in cell cycle G1 progression 1,which is also known as a vital tumor suppressor.